269 related articles for article (PubMed ID: 20333377)
1. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma.
Sun J; Chen LJ; Zhang GB; Jiang JT; Zhu M; Tan Y; Wang HT; Lu BF; Zhang XG
Cancer Immunol Immunother; 2010 Aug; 59(8):1163-71. PubMed ID: 20333377
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma.
Mao Y; Sun J; Wang WP; Zhang XG; Hua D
Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607
[TBL] [Abstract][Full Text] [Related]
3. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer.
Loos M; Hedderich DM; Ottenhausen M; Giese NA; Laschinger M; Esposito I; Kleeff J; Friess H
BMC Cancer; 2009 Dec; 9():463. PubMed ID: 20035626
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients.
Bin Z; Guangbo Z; Yan G; Huan Z; Desheng L; Xueguang Z
J Surg Res; 2014 May; 188(2):396-403. PubMed ID: 24630518
[TBL] [Abstract][Full Text] [Related]
5. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
[TBL] [Abstract][Full Text] [Related]
6. [Expression characteristics and clinical significance of B7-H3 in colorectal cancer].
Shao Y; Shi T; Guo L; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 May; 40(5):435-442. PubMed ID: 38790100
[TBL] [Abstract][Full Text] [Related]
7. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
Xu YH; Zhang GB; Wang JM; Hu HC
Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.
Sun TW; Gao Q; Qiu SJ; Zhou J; Wang XY; Yi Y; Shi JY; Xu YF; Shi YH; Song K; Xiao YS; Fan J
Cancer Immunol Immunother; 2012 Nov; 61(11):2171-82. PubMed ID: 22729558
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of B7-H3 expression in human pancreatic cancer.
Yamato I; Sho M; Nomi T; Akahori T; Shimada K; Hotta K; Kanehiro H; Konishi N; Yagita H; Nakajima Y
Br J Cancer; 2009 Nov; 101(10):1709-16. PubMed ID: 19844235
[TBL] [Abstract][Full Text] [Related]
10. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
11. B7-h3 and its role in antitumor immunity.
Loos M; Hedderich DM; Friess H; Kleeff J
Clin Dev Immunol; 2010; 2010():683875. PubMed ID: 21127709
[TBL] [Abstract][Full Text] [Related]
12. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
[TBL] [Abstract][Full Text] [Related]
13. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.
Boorjian SA; Sheinin Y; Crispen PL; Farmer SA; Lohse CM; Kuntz SM; Leibovich BC; Kwon ED; Frank I
Clin Cancer Res; 2008 Aug; 14(15):4800-8. PubMed ID: 18676751
[TBL] [Abstract][Full Text] [Related]
14. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.
Hu X; Xu M; Hu Y; Li N; Zhou L
Cell Biochem Biophys; 2021 Jun; 79(2):397-405. PubMed ID: 33743142
[TBL] [Abstract][Full Text] [Related]
15. Epithelial and tumor-associated endothelial expression of B7-H3 in cervical carcinoma: relation with CD8+ intraepithelial lymphocytes, FIGO stage, and phosphohistone H3 (PHH3) reactivity.
Brustmann H; Igaz M; Eder C; Brunner A
Int J Gynecol Pathol; 2015 Mar; 34(2):187-95. PubMed ID: 25675190
[TBL] [Abstract][Full Text] [Related]
16. Associations of B7-H3 and B7-H4 Expression in Ductal Carcinoma In Situ of the Breast With Clinicopathologic Features and T-Cell Infiltration.
Kim NI; Park MH; Lee JS
Appl Immunohistochem Mol Morphol; 2020; 28(10):767-775. PubMed ID: 31714284
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
18. Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.
Katayama A; Takahara M; Kishibe K; Nagato T; Kunibe I; Katada A; Hayashi T; Harabuchi Y
Int J Oncol; 2011 May; 38(5):1219-26. PubMed ID: 21344157
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
[TBL] [Abstract][Full Text] [Related]
20. miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.
Meng F; Yang M; Chen Y; Chen W; Wang W
Cancer Immunol Immunother; 2021 Aug; 70(8):2247-2259. PubMed ID: 33492448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
